The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Satel, S. L.
* Articles by Kleber, H. D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Satel, S. L.
* Articles by Kleber, H. D.

Am J Psychiatry 1991; 148:1712-1716
Copyright © 1991 by American Psychiatric Association


REGULAR ARTICLES

Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study

SL Satel, LH Price, JM Palumbo, CJ McDougle, JH Krystal, F Gawin, DS Charney, GR Heninger and HD Kleber
Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, West Haven.

OBJECTIVE: This study was undertaken to document symptoms and changes in dopaminergic function emerging after abrupt cessation of cocaine use. METHOD: After admission, 22 patients with DSM-III-R cocaine dependence were observed drug free for 3 weeks. The patient-rated Ribicoff Abstinence Rating Scale, Symptom Rating Scale, Physical Symptom Scale, Patient Rated Anxiety Scale, Beck Depression Inventory, and visual analogue scales for 16 subjective states were completed daily, and nurses rated 13 patients with the global anxiety and depression items of the Short Clinical Rating Scale. Serial blood samples were obtained three times weekly, and the patients' levels of prolactin, growth hormone (GH), and homovanillic acid (HVA) were measured. Their prolactin and GH values were compared with those of matched normal subjects. RESULTS: A total of 62 subjective symptom variables were evaluated. At baseline, the symptom ratings were mildly elevated. At 3 weeks there were significant decreases from baseline in 28 variables and nearly significant decreases in six additional variables. Nurse-rated anxiety and depression also changed, but in a more variable pattern. There was a small but significant increase from baseline over time in plasma prolactin, but there were no significant changes in GH or HVA. The patients' prolactin and GH values did not differ from those of the normal subjects. CONCLUSIONS: These findings suggest that symptoms after inpatient cessation of uncomplicated cocaine addiction are relatively mild and decrease linearly over the first month. Evidence of dysregulated central dopamine function was limited. The findings do not support routine use of pharmacological agents in the inpatient management of such patients.


This article has been cited by other articles:


Home page
JAMAHome page
E. V. Nunes and F. R. Levin
Treatment of Depression in Patients With Alcohol or Other Drug Dependence: A Meta-analysis
JAMA, April 21, 2004; 291(15): 1887 - 1896.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. F. Weaver, M. A. E. Jarvis, and S. H. Schnoll
Role of the Primary Care Physician in Problems of Substance Abuse
Arch Intern Med, May 10, 1999; 159(9): 913 - 924.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. H. Mendelson and N. K. Mello
Management of Cocaine Abuse and Dependence
N. Engl. J. Med., April 11, 1996; 334(15): 965 - 972.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1991 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org